Keytruda® cuts distant spread in a rare aggressive skin cancer
Patients with a rare skin cancer who received an immunotherapy drug after surgery had a 42 percent lower risk of the cancer spreading to other parts of the body.
Study shows more aggressive breast cancer than expected for younger women
Women under 50 are being diagnosed with cancer more often than screening guidelines predict, with a large percentage of these cancers being invasive and harder to treat.
COVID-19 vaccine may have boosted survival in advanced lung cancer patients
Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.
Slow release device eliminates bladder cancer in 82% of patients
A new slow-release chemotherapy system may be a more effective treatment for common bladder cancer than current therapy, according to results of a new clinical trial.
Could GLP-1 weight-loss drugs boost survival for colon cancer patients?
Colon cancer patients taking GLP-1 medications were less than half as likely to die within five years compared to those who weren’t on the drugs. – Image credit UC San Diego Today CANCER DIGEST – Nov. 15, 2025 – An analysis of data from nearly 7,000 colon cancer patients treated at cancer centers throughout California showed that patients who were taking a class of drug called glucagon-like peptide-1 (GLP-1) were more likely to survive compared to similar patients who were no
Niraparib nearly doubles progression-free survival in prostate cancer with specific genetic mutations
Men with prostate cancer whose tumors have specific genetic mutations saw a nearly 50 percent reduction in the risk of cancer progression when they received naraparib.
